,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['paradigm', 'breast', 'enhertu']
enhertu benefit in her2-low breast cancer wows at asco; signals shifting therapy, dx paradigms more medical news at #oncology #medtwitter #meded #mednews 
#Oncology news from major publishers consolidated for a more streamlined industry news experience.????